Redpoint Investment Management’s Abiomed Inc ABMD Stock Holding History

Redpoint Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$272K	Sell	1,106 -427	-28%	-$115K	0.04%	487
2022 Q2	$379K	Hold	1,533	–	–	0.04%	443
2022 Q1	$508K	Hold	1,533	–	–	0.05%	412
2021 Q4	$551K	Hold	1,533	–	–	0.04%	431
2021 Q3	$499K	Sell	1,533 -90	-6%	-$30.5K	0.04%	449
2021 Q2	$507K	Hold	1,623	–	–	0.04%	454
2021 Q1	$517K	Hold	1,623	–	–	0.04%	421
2020 Q4	$526K	Hold	1,623	–	–	0.05%	347
2020 Q3	$450K	Sell	1,623 -2,036	-56%	-$587K	0.05%	378
2020 Q2	$884K	Sell	3,659 -221	-6%	-$44.4K	0.05%	375
2020 Q1	$563K	Hold	3,880	–	–	0.04%	399
2019 Q4	$662K	Hold	3,880	–	–	0.03%	428
2019 Q3	$690K	Buy	3,880 +242	+7%	+$52.3K	0.04%	425
2019 Q2	$948K	Hold	3,638	–	–	0.05%	378
2019 Q1	$1.04M	Hold	3,638	–	–	0.05%	380
2018 Q4	$1.18M	Buy	3,638 +2,681	+280%	+$931K	0.07%	331
2018 Q3	$430K	Hold	957	–	–	0.02%	448
2018 Q2	$391K	Buy	+957	New	+$347K	0.02%	428

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Redpoint Investment Management's ABMD Position: Q3 2022 in Review

Redpoint Investment Management reduced its Abiomed Inc (ABMD) stake by 28% in Q3 2022, selling an estimated $115K and leaving 1,106 shares worth $272K. The position accounts for 0.04% of the portfolio, ranked #487.

Redpoint Investment Management first reported a position in ABMD in Q2 2018 and has held it in 18 quarters since. The position peaked at $1.18M in Q4 2018. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

Redpoint Investment Management held 1,106 shares of Abiomed Inc worth $272K as of Q3 2022.
Redpoint Investment Management sold 427 Abiomed Inc shares in Q3 2022, an estimated $115K.
Abiomed Inc made up 0.04% of Redpoint Investment Management's portfolio in Q3 2022, its #487 holding.
Redpoint Investment Management first reported a position in Abiomed Inc in Q2 2018 and has held it in 18 quarters since.
Redpoint Investment Management's Abiomed Inc position peaked at $1.18M in Q4 2018.
517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.